Our top pick for
Douglas Emmett, Inc is a reit—office business based in the US. Douglas Emmett shares (DEI) are listed on the NYSE and all prices are listed in US Dollars. Douglas Emmett employs 713 staff and has a trailing 12-month revenue of around USD$944.5 million.
Since the stock market crash in March caused by coronavirus, Douglas Emmett's share price has had significant negative movement.
Its last market close was USD$32.08, which is 27.94% down on its pre-crash value of USD$44.52 and 38.51% up on the lowest point reached during the March crash when the shares fell as low as USD$23.16.
If you had bought USD$1,000 worth of Douglas Emmett shares at the start of February 2020, those shares would have been worth USD$590.91 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$771.84.
|Latest market close||USD$32.08|
|52-week range||USD$23.16 - USD$45.59|
|50-day moving average||USD$26.034|
|200-day moving average||USD$28.7643|
|Wall St. target price||USD$31.64|
|Dividend yield||USD$1.12 (4.61%)|
|Earnings per share (TTM)||USD$1.872|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-17)||-1.78%|
|1 month (2020-10-23)||27.30%|
|3 months (2020-08-25)||13.48%|
|6 months (2020-05-23)||N/A|
|1 year (2019-11-25)||-26.62%|
|2 years (2018-11-23)||-9.74%|
|3 years (2017-11-24)||-21.60%|
|5 years (2015-11-25)||3.25%|
Valuing Douglas Emmett stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Douglas Emmett's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Douglas Emmett's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 13x. In other words, Douglas Emmett shares trade at around 13x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Douglas Emmett's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 9.09. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Douglas Emmett's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Douglas Emmett's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$585.5 million.
The EBITDA is a measure of a Douglas Emmett's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$944.5 million|
|Operating margin TTM||26.6%|
|Gross profit TTM||USD$645.4 million|
|Return on assets TTM||1.75%|
|Return on equity TTM||9.15%|
|Market capitalisation||USD$4.2 billion|
TTM: trailing 12 months
There are currently 4.2 million Douglas Emmett shares held short by investors – that's known as Douglas Emmett's "short interest". This figure is 18.9% up from 3.6 million last month.
There are a few different ways that this level of interest in shorting Douglas Emmett shares can be evaluated.
Douglas Emmett's "short interest ratio" (SIR) is the quantity of Douglas Emmett shares currently shorted divided by the average quantity of Douglas Emmett shares traded daily (recently around 1.7 million). Douglas Emmett's SIR currently stands at 2.48. In other words for every 100,000 Douglas Emmett shares traded daily on the market, roughly 2480 shares are currently held short.
However Douglas Emmett's short interest can also be evaluated against the total number of Douglas Emmett shares, or, against the total number of tradable Douglas Emmett shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Douglas Emmett's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Douglas Emmett shares in existence, roughly 20 shares are currently held short) or 0.0351% of the tradable shares (for every 100,000 tradable Douglas Emmett shares, roughly 35 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Douglas Emmett.
Find out more about how you can short Douglas Emmett stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Douglas Emmett.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 18.61
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Douglas Emmett's overall score of 18.61 (as at 10/01/2020) is excellent – landing it in it in the 16th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Douglas Emmett is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 0.89/100
Social score: 4.63/100
Governance score: 3.09/100
|Total ESG score||18.61|
|Total ESG percentile||16.3|
Dividend payout ratio: 59.89% of net profits
Recently Douglas Emmett has paid out, on average, around 59.89% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.61% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Douglas Emmett shareholders could enjoy a 4.61% return on their shares, in the form of dividend payments. In Douglas Emmett's case, that would currently equate to about $1.12 per share.
Douglas Emmett's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Douglas Emmett's most recent dividend payout was on 15 October 2020. The latest dividend was paid out to all shareholders who bought their shares by 29 September 2020 (the "ex-dividend date").
Over the last 12 months, Douglas Emmett's shares have ranged in value from as little as $23.16 up to $45.59. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Douglas Emmett's is 0.6856. This would suggest that Douglas Emmett's shares are less volatile than average (for this exchange).
Douglas Emmett, Inc. (DEI) is a fully integrated, self-administered and self-managed real estate investment trust (REIT), and one of the largest owners and operators of high-quality office and multifamily properties located in the premier coastal submarkets of Los Angeles and Honolulu. Douglas Emmett focuses on owning and acquiring a substantial share of top-tier office properties and premier multifamily communities in neighborhoods that possess significant supply constraints, high-end executive housing and key lifestyle amenities.
Everything we know about the Qilian International Holding Group IPO, plus information on how to buy in.
Everything we know about the AbCellera Biologics IPO, plus information on how to buy in.
Steps to owning and managing CALM, with 24-hour and historical pricing before you buy.
Steps to owning and managing CRR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BG, with 24-hour and historical pricing before you buy.
Steps to owning and managing BCLI, with 24-hour and historical pricing before you buy.
Steps to owning and managing BLBD, with 24-hour and historical pricing before you buy.
Steps to owning and managing BDTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing RILYO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASPN, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.